Conmed (CNMD) Tops Q3 EPS by 1c
Tweet
Share
E-mailGet Alerts CNMD Hot Sheet
Price: $46.15 -1.66%
EPS Growth %: -7.4%
Financial Fact:
Gross profit: 101.21M
Today's EPS Names:
VIVO, BIOX, PMCB, More
EPS Growth %: -7.4%
Financial Fact:
Gross profit: 101.21M
Today's EPS Names:
VIVO, BIOX, PMCB, More
Join SI Premium – FREE
Conmed (NASDAQ: CNMD) reported Q3 EPS of $0.41, $0.01 better than the analyst estimate of $0.40. Revenue for the quarter came in at $184.8 million versus the consensus estimate of $180.13 million.
Conmed reaffirmed FY2016 guidance.
For earnings history and earnings-related data on Conmed (CNMD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Oracle reports earnings today: AI spending bet faces its toughest test yet
- Casey's General Stores (CASY) PT Lowered to $720 at UBS on Peak Fuel Margin Concerns
- GLJ Research rips into SolarEdge Technologies (SEDG): 'We'd be aggressively fading this move'
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
